$15.12 (5.15%)

Volume: 317.06k

Closed: Dec 01, 2022

Hollow Logo Score: -4.136

FibroGen Stock Forecast

$15.12 (5.15%)

Volume: 317.06k

Closed: Dec 01, 2022

Score Hollow Logo -4.136

FibroGen Stock Statistics NASDAQ:FGEN

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-11-21 - 2022-12-01 SELL 8.89
2022-11-18 - 2022-11-21 HOLD -4.96
2022-11-14 - 2022-11-18 SELL -4.38
2022-11-10 - 2022-11-14 BUY -5.45
2022-11-08 - 2022-11-10 SELL 14.20

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE